These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30471292)

  • 1. The Mechanistic Impact of N-Glycosylation on Stability, Pharmacokinetics, and Immunogenicity of Therapeutic Proteins.
    Zhou Q; Qiu H
    J Pharm Sci; 2019 Apr; 108(4):1366-1377. PubMed ID: 30471292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-glycans of complex glycosylated biopharmaceuticals and their impact on protein clearance.
    Higel F; Sandl T; Kao CY; Pechinger N; Sörgel F; Friess W; Wolschin F; Seidl A
    Eur J Pharm Biopharm; 2019 Jun; 139():123-131. PubMed ID: 30905778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.
    Liu L
    J Pharm Sci; 2015 Jun; 104(6):1866-1884. PubMed ID: 25872915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms.
    Wada R; Matsui M; Kawasaki N
    MAbs; 2019; 11(2):350-372. PubMed ID: 30466347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycan characterization of biopharmaceuticals: Updates and perspectives.
    Planinc A; Bones J; Dejaegher B; Van Antwerpen P; Delporte C
    Anal Chim Acta; 2016 May; 921():13-27. PubMed ID: 27126786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation of Therapeutic Proteins: A Critical Quality Attribute.
    Delobel A
    Methods Mol Biol; 2021; 2271():1-21. PubMed ID: 33907996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using glyco-engineering to produce therapeutic proteins.
    Dicker M; Strasser R
    Expert Opin Biol Ther; 2015; 15(10):1501-16. PubMed ID: 26175280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-glycosylation and its role in therapeutic proteins.
    Thompson N; Wakarchuk W
    Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36214107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo deglycosylation of recombinant glycoproteins in tobacco BY-2 cells.
    Herman X; Far J; Peeters M; Quinton L; Chaumont F; Navarre C
    Plant Biotechnol J; 2023 Sep; 21(9):1773-1784. PubMed ID: 37266972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro.
    Liu WC; Lin YL; Spearman M; Cheng PY; Butler M; Wu SC
    J Virol; 2016 Jul; 90(13):6085-6096. PubMed ID: 27099319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant plant-derived human IgE glycoproteomics.
    Montero-Morales L; Maresch D; Castilho A; Turupcu A; Ilieva KM; Crescioli S; Karagiannis SN; Lupinek C; Oostenbrink C; Altmann F; Steinkellner H
    J Proteomics; 2017 May; 161():81-87. PubMed ID: 28400175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans.
    Hollister J; Grabenhorst E; Nimtz M; Conradt H; Jarvis DL
    Biochemistry; 2002 Dec; 41(50):15093-104. PubMed ID: 12475259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-glycan sialylation in a silkworm-baculovirus expression system.
    Suganuma M; Nomura T; Higa Y; Kataoka Y; Funaguma S; Okazaki H; Suzuki T; Fujiyama K; Sezutsu H; Tatematsu KI; Tamura T
    J Biosci Bioeng; 2018 Jul; 126(1):9-14. PubMed ID: 29433940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in Pichia pastoris.
    Choi BK; Warburton S; Lin H; Patel R; Boldogh I; Meehl M; d'Anjou M; Pon L; Stadheim TA; Sethuraman N
    Appl Microbiol Biotechnol; 2012 Aug; 95(3):671-82. PubMed ID: 22569635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of N-/O-glycans assembled on proteins in yeasts.
    Thak EJ; Kim J; Lee DJ; Kim JY; Kang HA
    J Microbiol; 2018 Jan; 56(1):11-23. PubMed ID: 29299842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human rhabdomyosarcoma cell line TE671--Towards an innovative production platform for glycosylated biopharmaceuticals.
    Rosenlöcher J; Weilandt C; Sandig G; Reinke SO; Blanchard V; Hinderlich S
    Protein Expr Purif; 2015 Nov; 115():83-94. PubMed ID: 26272370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation of Recombinant Anticancer Therapeutics in Different Expression Systems with Emerging Technologies.
    Nadeem T; Khan MA; Ijaz B; Ahmed N; Rahman ZU; Latif MS; Ali Q; Rana MA
    Cancer Res; 2018 Jun; 78(11):2787-2798. PubMed ID: 29789420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation Analysis of Therapeutic Glycoproteins Produced in CHO Cells.
    Carillo S; Mittermayr S; Farrell A; Albrecht S; Bones J
    Methods Mol Biol; 2017; 1603():227-241. PubMed ID: 28493134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris.
    Wang S; Rong Y; Wang Y; Kong D; Wang PG; Chen M; Kong Y
    Microb Cell Fact; 2020 Jan; 19(1):7. PubMed ID: 31931833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.